Compare Summit Therapeutics Inc (SMMT) vs YieldMax Universe Fund of Option Income ETFs (YMAX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Summit Therapeutics Inc vs YieldMax Universe Fund of Option Income ETFs — how do they compare? Summit Therapeutics Inc trades at $14.57 (market cap $10.48B), while YieldMax Universe Fund of Option Income ETFs trades at $7.7. Which is the better fit depends on your goals.
| SMMT | YMAX | |
|---|---|---|
Market Cap | $10.48B | — |
Sector | Health | Income / Options Overlay |
52-Week High | $29.32 | $14.00 |
52-Week Low | $13.05 | $7.51 |
Enterprise Value | $9.90B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Summit Therapeutics Inc
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →About YieldMax Universe Fund of Option Income ETFs
YMAX is an actively managed 'fund of funds' that provides equal-weighted exposure to the full suite of YieldMax option income ETFs. It is designed to generate high current income by aggregating the premiums from various single-stock and thematic covered call strategies, offering a diversified approach to high-yield option investing.
Read more on YMAX →
